Which of the following is a recommended consideration when prescribing ACE inhibitors?

When prescribing ACE inhibitors, patients with congestive heart failure is a significant consideration due to the therapeutic benefits these medications provide. ACE inhibitors work by inhibiting the angiotensin-converting enzyme, leading to vasodilation, reduced blood pressure, and decreased workload on the heart. This is particularly beneficial for patients with congestive heart failure, as it helps improve symptoms such as dyspnea and exercise tolerance and can also enhance overall survival rates by reducing the risk of heart failure exacerbations.

For individuals with congestive heart failure, the management of fluid status and systemic vascular resistance is crucial, and ACE inhibitors play a key role in this regard. Additionally, these drugs can help mitigate the adverse effects associated with heart failure by preventing cardiac remodeling following myocardial injury.

Other options listed present considerations where the use of ACE inhibitors may not be appropriate or are areas of caution. Normotensive patients may not benefit significantly from the medication, and using it in patients with a history of angioedema poses a risk due to potential exacerbation of allergic reactions. Furthermore, ACE inhibitors are contraindicated in women planning to become pregnant due to their teratogenic effects, especially during the second and third trimesters of pregnancy.